A cooperative agreement-assisted program which provides support to community-based oncologists to participate in clinical trials sponsored by the clinical cooperative groups and/or cancer centres in the US.
The application guidelines for the Community Clinical Oncology Program require each CCOP to affiliate with at least one, but no more than five, NCI-supported research bases for the purpose of enrolling patients in cancer treatment and cancer control clinical trials.
In the decade since the Community Clinical Oncology Program has become operational, some clinical cooperative groups have encouraged CCOP physicians to join their scientific committees, to design protocols for the administration of clinical trials, and to chair clinical research studies, while others have discouraged, or given only weak support, to such participation.
The study period covers six time points that span two Community Clinical Oncology Program funding cycles -- CCOP-I and CCOP-II.
These findings have several policy implications for the Community Clinical Oncology Program and for other kinds of health care strategic partnerships.
For community-based health research initiatives, such as the Community Clinical Oncology Program and the Community Programs for Clinical Research on AIDS, the study findings suggest that the number of community clinicians who attend scientific meetings in the first two years of the clinical research partnership has a significant influence on meeting attendance and protocol use in later years.
Harris is a member of the National Cancer Institute's Special Review Committee where he is responsible for the review of Community Clinical Oncology Programs, and Associate Editor for Pediatric Oncology for the scientific journal Cancer Investigation.
The NCORP opportunity was established after the National Cancer Institute made the decision to end funding as of July 31, 2014 for federally-funded clinical trials in the community setting through Community Clinical Oncology Programs (CCOP).
The Beaumont Cancer Institute is one of only 47 Community Clinical Oncology Programs in the country designated by the National Cancer Institute to provide patients with access to leading-edge cancer clinical research trials.